FOLLOW-UP VESSEL WALL MR IMAGING TO EXPLORE SEX-DIFFERENCES OF INTRACRANIAL ARTERIAL WALL CHANGES AND INTRACRANIAL ATHEROSCLEROTIC PLAQUE TREATMENT EFFICACY
-
- STATUS
- Recruiting
Summary
Mortality related to cardiovascular disease in the US is improving. Yet the rate of decline is less for women than for men. Women's health is unique due to the varying reproductive stages, and differences are further heightened by sex-specific molecular and cellular characteristics of the heart and vasculature. These biophysiological distinctions may help explain sex disparities in risk factor burden and outcomes after a stroke. While women have some unique risk factors, the predominant risk factors for stroke, such as hypertension and hyperlipidemia, are similar between the sexes. However, the frequency of each risk factor varies resulting in differing population attributable risks. Effective screening and early management of these modifiable risk factors will have the greatest impact to stroke prevention. The same risk factors for cardiovascular disease also underlie the development of intracranial atherosclerotic disease (ICAD), a leading cause of stroke. Yet surprisingly, the development and progression of ICAD has not been explored in women despite the intimate association with stroke. High-resolution vessel wall MR imaging (VWI) permits visualization of vessel wall changes and may potentially serve as a noninvasive screening test for populations of women for early ICAD detection. We propose a study to prospectively evaluate women and men with stroke using VWI to estimate the prevalence of vessel wall abnormalities leading to stroke. Early detection of vessel wall changes in correlation with modifiable risk factors will help us identify opportunities for early prevention of stroke in women. Additionally, longitudinal imaging data and statin non-adherence questionnaires will provide data to evaluate the efficiency of stroke treatment post intervention and identify reasons for non-adherence.
Details
| Condition | neurology |
|---|---|
| Age | 99years or below |
| Clinical Study Identifier | TBD |
| Last Modified on | 19 February 2024 |
Eligibility
How to participate?
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.